Furthermore, the downregulation of LINC00665 reduced drug resistance in gemcitabine-resistant CCA cells, while its overexpression increased gemcitabine resistance in CCA-sensitive cells, indicating its role in enhancing chemoresistance in CCA cells [299]. Here, LINC00665 is linked to cholangiocarcinoma.